Docs rate exhibits as better than ads

Share this article:
Physicians prefer exhibits at medical meetings to some other modes of learning about new drugs and technologies, a study suggests.

M|C Communications polled attendees at a Pri-Med meeting earlier this year—212 before and 182 after. The Healthcare Convention & Exhibitors Association presented the data in June.

Sixty-six percent favor getting information on new drugs from exhibitors, vs. 16% who prefer journal ads and 69% who prefer journal articles. For medical technology information, most clearly prefer exhibitors.

In addition, almost half said their offices restrict access by detailers or plan to within the next six months.

Share this article:
close

Next Article in News

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.